Post-approval studies (Phase 4)Study completedNCT02003534
What this trial is testing
0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 376